Literature DB >> 17927476

Communication systems in the genus Burkholderia: global regulators and targets for novel antipathogenic drugs.

Pamela A Sokol1, Rebecca J Malott, Kathrin Riedel, Leo Eberl.   

Abstract

The genus Burkholderia not only contains the primary pathogens Burkholderia pseudomallei and Burkholderia mallei but also several species that have emerged as opportunistic pathogens in persons suffering from cystic fibrosis or chronic granulomatous disease and immunocompromised individuals. Burkholderia species utilize quorum-sensing (QS) systems that rely on N-acyl-homoserine lactone (AHL) signal molecules to express virulence factors and other functions in a population-density-dependent manner. Most Burkholderia species employ the CepIR QS system, which relies on N-octanoyl-homoserine lactone. However, some strains harbour multiple QS systems and produce numerous AHLs. QS systems have been demonstrated to be essential for full virulence in various infection models and, thus, these regulatory systems represent attractive targets for the development of novel therapeutics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17927476     DOI: 10.2217/17460913.2.5.555

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  24 in total

1.  The Burkholderia cenocepacia LysR-type transcriptional regulator ShvR influences expression of quorum-sensing, protease, type II secretion, and afc genes.

Authors:  Eoin P O'Grady; David T Nguyen; Laure Weisskopf; Leo Eberl; Pamela A Sokol
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

2.  Differential modulation of Burkholderia cenocepacia virulence and energy metabolism by the quorum-sensing signal BDSF and its synthase.

Authors:  Yinyue Deng; Calvin Boon; Leo Eberl; Lian-Hui Zhang
Journal:  J Bacteriol       Date:  2009-10-02       Impact factor: 3.490

3.  Functional quorum sensing systems are maintained during chronic Burkholderia cepacia complex infections in patients with cystic fibrosis.

Authors:  Suzanne A McKeon; David T Nguyen; Duber F Viteri; James E A Zlosnik; Pamela A Sokol
Journal:  J Infect Dis       Date:  2010-12-14       Impact factor: 5.226

4.  Present and future therapeutic strategies for melioidosis and glanders.

Authors:  D Mark Estes; Steven W Dow; Herbert P Schweizer; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

5.  Structural and functional characterization of diffusible signal factor family quorum-sensing signals produced by members of the Burkholderia cepacia complex.

Authors:  Yinyue Deng; Ji'en Wu; Leo Eberl; Lian-Hui Zhang
Journal:  Appl Environ Microbiol       Date:  2010-05-28       Impact factor: 4.792

6.  A Burkholderia cenocepacia orphan LuxR homolog is involved in quorum-sensing regulation.

Authors:  Rebecca J Malott; Eoin P O'Grady; Jessica Toller; Silja Inhülsen; Leo Eberl; Pamela A Sokol
Journal:  J Bacteriol       Date:  2009-02-06       Impact factor: 3.490

7.  Intraspecies signaling involving the diffusible signal factor BDSF (cis-2-dodecenoic acid) influences virulence in Burkholderia cenocepacia.

Authors:  Robert P Ryan; Yvonne McCarthy; Steven A Watt; Karsten Niehaus; J Maxwell Dow
Journal:  J Bacteriol       Date:  2009-05-29       Impact factor: 3.490

8.  Reducing virulence of the human pathogen Burkholderia by altering the substrate specificity of the quorum-quenching acylase PvdQ.

Authors:  Gudrun Koch; Pol Nadal-Jimenez; Carlos R Reis; Remco Muntendam; Marcel Bokhove; Elena Melillo; Bauke W Dijkstra; Robbert H Cool; Wim J Quax
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

9.  Identification of specific and universal virulence factors in Burkholderia cenocepacia strains by using multiple infection hosts.

Authors:  Susanne Uehlinger; Stephan Schwager; Steve P Bernier; Kathrin Riedel; David T Nguyen; Pamela A Sokol; Leo Eberl
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

10.  Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics.

Authors:  Deborah R Yoder-Himes; Konstantinos T Konstantinidis; James M Tiedje
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.